The SBIC & Commercial Finance industry is positioned to benefit from higher interest rates and wider investment spreads, with resilient economic growth supporting demand for customized financing. However, rising concerns around private credit, increased non-accruals, and credit losses pressure asset quality. Three stocks highlighted are Goldman Sachs BDC (Zacks Rank #1), Gladstone Investment (Zacks Rank #1), and Runway Growth Finance (Zacks Rank #2), all expected to benefit from elevated rates given their floating-rate portfolios.

The SBIC & Commercial Finance industry is positioned to benefit from higher interest rates, which boost investment income on floating-rate portfolios, and regulatory changes enhancing funding flexibility. However, rising concerns about private credit, increased non-accruals, and credit losses pose risks to asset quality. Three stocks are highlighted as well-positioned: Goldman Sachs BDC, Gladstone Investment Corporation, and Runway Growth Finance Corp.

Runway Growth Finance Corp. (RWAY) has received a Zacks Rank #2 (Buy) rating due to strong upward earnings estimate revisions. Analysts have raised consensus estimates 6.12% for the current quarter and 14.47% for the full year, with five positive revisions and no negative ones in the past month. The stock has gained 17.2% over the past four weeks, reflecting investor confidence in its earnings growth prospects.

Runway Growth Finance Corp. (NASDAQ: RWAY) announced a second quarter 2026 cash distribution of $0.33 per share. The dividend will be paid on June 2, 2026, to shareholders of record as of May 18, 2026. The company intends to distribute substantially all available earnings quarterly, subject to board discretion and regulatory compliance.

Runway Growth Finance Corp. completed its acquisition of SWK Holdings Corporation for $249.0 million, expanding its total assets to $1.2 billion and increasing healthcare and life sciences exposure to 32%. The company funded four investments totaling $17.6 million in Q1 2026 and experienced $19.0 million in liquidity events. CEO David Spreng returned to Chief Investment Officer role, and the investment adviser contributed an additional $9.0 million in cash to SWK stockholders.

Runway Growth Finance Corp. (NASDAQ: RWAY) announced a first quarter 2026 cash distribution of $0.33 per share. The dividend will be paid on March 24, 2026, to shareholders of record as of March 10, 2026. The company intends to distribute substantially all available earnings on a quarterly basis and maintains a dividend reinvestment plan for its stockholders.

Runway Growth Finance Corp. (RWAY) announced an underwritten offering of unsecured notes to raise capital for repaying existing debt, including redemption of $51.75 million in 8.00% Notes due 2027, and to finance its acquisition of SWK Holdings Corporation. The notes are expected to trade on Nasdaq within 30 days of issuance.

Runway Growth Finance Corp. declared a fourth quarter 2025 cash dividend of $0.33 per share, with payment scheduled for December 3, 2025. The company focuses on providing flexible capital solutions to late- and growth-stage companies.

Law firm Monteverde & Associates is investigating the proposed merger between SWK Holdings Corporation and Runway Growth Finance Corp, examining the fairness of the transaction terms for shareholders.

Runway Growth Finance Corp will acquire SWK Holdings for approximately $220 million in a NAV-for-NAV merger, which includes $75.5 million in stock and $145 million in cash, with an expected mid-single-digit NII accretion.

Runway Growth Finance Corp. announced a definitive merger agreement to acquire SWK Holdings Corporation, a life science specialty finance company, for approximately $220 million. The transaction will expand Runway Growth's portfolio, increase healthcare investments, and enhance its financial profile.

Runway Growth Finance Corp. announced a merger agreement to acquire SWK Holdings Corporation, a life science specialty finance company, for approximately $220 million. The transaction will expand Runway Growth's healthcare investments and total assets to $1.3 billion, with expected mid-single-digit net investment income accretion.